Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-24 @ 11:24 PM
NCT ID:
NCT07272356
Eligibility Criteria:
Inclusion Criteria:
* Adults (18 years or older)
* Verified systemic therapy-naive biopsy-proven NSCLC, stages from Tis to T2; or oligometastatic peripheral (≤ 5 lesions) lung disease;
* All lesions are ≤3 cm in size and accessible for surgery, ablation or SBRT;
* No local nodal or distant metastatic disease on diagnostic imaging;
* Documented agreement on the recommended curative treatment by a multidisciplinary team, including a pulmonologist, interventional radiologist, radiation therapist, thoracic surgeon, and oncologist;
* Documented patient's agreement to receive the intended therapy and to participate in this study via a signed informed consent form.
Exclusion Criteria:
* Central lung tumors (\<2 cm from the main bronchi or hilum);
* \>5 or diffuse lung lesions, or prior local treatment to the same lesion;
* Major comorbidities, physical or social limitations precluding trial participation;
* Contraindications to general anesthesia, inability to temporarily withdraw antiplatelet therapy, or evidence of severe coagulopathy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07272356
Study Brief:
Protocol Section:
NCT07272356